F2 and pertussis: The researchers in the Gothenburg study concluded that PT “is both an essential and alone sufficient antigen in acellular pertussis vaccines [76].” However, after three years of surveillance, protection in the PT-only group was lower than that observed in the two-component vaccine group [77].